Cargando…
A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic
Autores principales: | Jacob, DeAsia D., Gatherwright, James R., Djohan, Risal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908616/ https://www.ncbi.nlm.nih.gov/pubmed/36812876 http://dx.doi.org/10.1016/j.bjps.2023.01.043 |
Ejemplares similares
-
Abstract 140: Upper Extremity Infections In The Solid Organ Transplant Population: The Cleveland Clinic Experience
por: Aliotta, Rachel E., et al.
Publicado: (2020) -
Abstract: Prospective Randomized Blinded Trial Investigating Pain Control and Length of Stay Measures with Transversus Abdominis Plane Block Performed with Liposomal Bound Bupivicaine (Exparel®) in Women Undergoing Mastectomy with Abdominal-Based Reconstruction
por: Gatherwright, James, et al.
Publicado: (2017) -
Artificial womb: a paradigm shift for saving extremely premature infants
por: Huang, Zhelan, et al.
Publicado: (2023) -
Nerve Transfers to Restore upper Extremity Function: A Paradigm Shift
por: Moore, Amy M.
Publicado: (2014) -
Beyond COVID-19—a paradigm shift in infection management?
por: Vehreschild, Maria J G T, et al.
Publicado: (2021)